Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

Documenti analoghi

• Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
  di: Lachin, John M., et al.
  Pubblicazione: (2011)
• Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
  di: Kahn, Steven E., et al.
  Pubblicazione: (2010)
• Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin
  di: HEMAUER, Sarah J., et al.
  Pubblicazione: (2010)
• Pharmacodynamics of glyburide, metformin and glyburide/metformin combination therapy in the treatment of gestational diabetes mellitus
  di: Shuster, Diana L., et al.
  Pubblicazione: (2020)
• Review of metformin and glyburide in the management of gestational diabetes
  di: Carroll DG, et al.
  Pubblicazione: (2015-01-01)